Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: A 2-year randomized controlled study

Psychological Medicine

Volumn 40, Issue 1, 2010, Pages 73-84

  Girn, M ^a   Fernndez Yaez, A ^b   Ma Alvarenga, S ^c   Molina Habas, A ^d   Nolasco, A ^e   Gmez Beneyto, M ^f,g  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b Florida Babel Mental Health Centre   (Spain)

^c Petrer Mental Health Centre   (Spain)

^d Ciutat Jard Mental Health Centre   (Spain)

^e UNIVERSITY OF ALICANTE   (Spain)

^f UNIVERSITY OF VALENCIA   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Family burden; Family intervention; Relapse; Schizophrenia; Social functioning

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CAREGIVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST OF ILLNESS; FAMILY THERAPY; FEMALE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOSIS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SCHIZOPHRENIA; SOCIAL ADAPTATION; SPAIN; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; CAREGIVERS; COMBINED MODALITY THERAPY; COST OF ILLNESS; FAMILY THERAPY; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; RECURRENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT; SPAIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 76649135819     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291709006126     Document Type: Article

References (48)

1. APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC.
2. Arevalo J, Vizcarro C (1989). Expressed emotion and course of schizophrenia in a Spanish sample [in Spanish]. Análisis y Modificación de Conducta 15, 3-24.
3. Barrowclough C, Haddock G, Tarrier N, Lewis SW, Moring J, O'Brien R, Schofield N, McGovern J (2001). Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry 158, 1706-1713.
4. Barrowclough C, Tarrier N, Lewis S, Sellwood W, Mainwaring J, Quinn J, Hamlin C (1999). Randomised controlled effectiveness trial of a needs-based psychosocial intervention service for carers of people with schizophrenia. British Journal of Psychiatry 174, 505-511.
5. Bebbington P, Kuipers L (1994). The predictive utility of expressed emotion in schizophrenia: an aggregate analysis. Psychological Medicine 24, 707-718.
6. Bertelsen M, Jeppesen P, Petersen L, Thorup A, Øhlenschlaeger J, le Quach P, Christensen TØ, Krarup G, Jørgensen P, Nordentoft M (2008). Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial. Archives of General Psychiatry 65, 762-771.
7. Bradley GM, Couchman GM, Perlesz A, Nguyen AT, Singh B, Riess C (2006). Multiple-family group treatment for English-and Vietnamese-speaking families living with schizophrenia. Psychiatric Services 57, 521-530.
8. Butzlaff RL, Hooley JM (1998). Expressed emotion and psychiatric relapse: a meta-analysis. Archives of General Psychiatry 55, 547-552.
9. Canive JM, Sanz-Fuentenebro J, Vazquez C, Qualls C, Fuentenebro F, Tuason VB (1995). Family environment predictors of outcome in schizophrenic patients in Spain: a nine-month follow-up study. Acta Psychiatrica Scandinavica 92, 371-377.
10. Chien WT, Chan SW, Thompson DR (2006). Effects of a mutual support group for families of Chinese people with schizophrenia: 18-month follow-up. British Journal of Psychiatry 189, 41-49.
11. Chien WT, Wong KF (2007). A family psychoeducation group program for Chinese people with schizophrenia in Hong Kong. Psychiatric Services 58, 1003-1006.
12. Dyck DG, Short RA, Hendryx MS, Norell D, Myers M, Patterson T, McDonell MG, Voss WD, McFarlane WR (2000). Management of negative symptoms among patients with schizophrenia attending multiple-family groups. Psychiatric Services 51, 513-519.
13. Falloon IRH, Boyd JL, McGill CW, Williamson M, Razani J, Moss HB, Gilderman AM, Simpson GM (1985). Family management in the prevention of morbidity of schizophrenia: clinical outcome of a two-year longitudinal study. Archives of General Psychiatry 42, 887-896.
14. Garety PA, Fowler DG, Freeman D, Bebbington P, Dunn G, Kuipers E (2008). Cognitive-behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry 192, 412-423.
15. Girón M, Gómez-Beneyto M (1995). Relationship between family attitudes measured by the semantic differential and relapse in schizophrenia: a 2 year follow-up prospective study. Psychological Medicine 25, 365-371.
16. Girón M, Gómez-Beneyto M (1998). Relationship between empathic family attitude and relapse in schizophrenia: a two year follow-up study. Schizophrenia Bulletin 24, 619-627.
17. Girón, M, Gómez-Beneyto M (2004). Relationship between family attitudes and social functioning in schizophrenia: a nine month follow-up perspective study. Journal of Nervous and Mental Disease 192, 414-420.
18. Gómez-Beneyto M, Asencio A, Belenger MJ, Cebrian A, Cervera G, Lopis V, Salazar J, Soria A (1986). Deinstitutionalization of chronic mentally ill without community resources [in Spanish]. In Cronicidad en Psiquiatŕia (ed. J. Espinosa). Asociación Española de Neuropsiquiatría: Madrid.
19. Gutierrez E, Escudero V, Valero JA, Vázquez M, Castro J, Alvarez L, Baltar M, Blanco J, González I, Gómez I (1988). Expressed emotion and course of schizophrenia: II. Expressed emotion and course of schizophrenia in patients in remission [in Spanish]. Análisis y Modificación de Conducta 15, 275-317.
20. Haddock G, Barrowclough C, Tarrier N, Moring J, O'Brien R, Schofield N, Quinn J, Palmer S, Davies L, Lowens I, McGovern J, Lewis S (2003). Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18-month outcomes of a randomised controlled trial. British Journal of Psychiatry 183, 418-426.
21. Hazel NA, McDonell MG, Short RA (2004). Impact of multiple-family groups for outpatients with schizophrenia on caregivers' distress and resources. Psychiatric Services 55, 35-41.
22. Heinrichs DW, Hanlon TE, Carpenter WT (1984). The Quality of Life Scale: an instrument for rating the schizophrenia deficit syndrome. Schizophrenia Bulletin 10, 388-398.
23. Hilsenroth MJ, Ackerman SJ, Blagys MD, Baumann BD, Baity MR, Smith SR, Price JL, Smith CL, Heindselman TL, Mount MK, Holdwick Jr. DJ (2000). Reliability and validity of DSM IV Axis V. American Journal of Psychiatry 157, 1858-1863.
24. Hogarty GE, Anderson CM, Reiss DJ, Kornblith SJ, Greenwald DP, Ulrich RF, Carter M (1991). Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. II. Two-year effects of a controlled study on relapse and adjustment. Archives of General Psychiatry 48, 340-347.
25. Krawiecka M, Goldberg D, Vaughan M (1977). A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatrica Scandinavica 55, 299-308.
26. Kuipers L, Leff JP, Lam D (2002). Family Work for Schizophrenia: A Practical Guide. Gaskell (Royal College of Psychiatrists): London.
27. Magliano L, Fiorillo A, Fadden G, Gair F, Economou M, Kallert T, Schellong J, Xavier M, Gonçalves Pereira M, Torres Gonzales F, Palma-Crespo A, Maj M (2005). Effectiveness of a psychoeducational intervention for families of patients with schizophrenia: preliminary results of a study funded by the European Commission. World Psychiatry 4, 45-49.
28. Magliano L, Fiorillo A, Malangone C, De Rosa C, Maj M (2006). Patient functioning and family burden in a controlled, real-world trial of family psychoeducation for schizophrenia. Psychiatric Services 57, 1784-1791.
29. Mañá S, Ivorra J, Girón M (1998). Adaptation and reliability of the Disability Assessment Schedule in psychiatric patients (WHO) [in Spanish]. Revista de Psiquiatŕia de la Facultad de Medicina de Barcelona 25, 43-48.
30. McDonell MG, Short RA, Berry CM, Dyck DG (2003). Burden in schizophrenia caregivers: impact of family psychoeducation and awareness of patient suicidality. Family Process 42, 91-103.
31. Montero I, Gómez-Beneyto M, Ruiz, I, Puche E, Adam A (1992). The influence of family expressed emotion on the course of schizophrenia in a sample of Spanish patients: a two-year follow-up study. British Journal of Psychiatry 161, 217-222.
32. Nuechterlein KH, Dawson ME, Gitlin M, Ventura J, Goldstein MJ, Snyder KS, Yee CM, Mintz J (1992). Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress. Schizophrenia Bulletin 18, 387-425.
33. Perez-Fuster A, Ballester-Gracia M, Giron-Gimenez M, Gomez-Beneyto M (1989). Reliability, validity and sensitivity to change of the psychiatric evaluation scale of Krawiecka [in Spanish]. Actas Luso Espanolas de Neuroloǵia, Psiquiatŕia y Ciencias Afines 17, 111-118.
34. Pfammater M, Martin-Junghan U, Dieter-Brenner H (2006). Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses. Schizophrenia Bulletin 32, 64-80.
35. Pharoah FM, Mari J, Rathbone J, Wong W (2006). Family intervention for schizophrenia. In The Cochrane Library, Issue 4. John Wiley & Sons, Ltd: Chichester.
36. Phillips L (1953). Case history data and prognosis in schizophrenia. Journal ofNervous and Mental Disease 117, 551-1525
37. Platt S, Weyman A, Hirsch S, Hewett S (1980). The Social Behaviour Assessment Schedule (SBAS): rationale, contents, scoring and reliability of a new interview schedule. Social Psychiatry 15, 43-55.
38. Provencher HL, Mueser KT (1997). Positive and negative symptom behaviors and caregiver burden in the relatives of persons with schizophrenia. Schizophrenia Research 26, 71-80.
39. Roick C, Heider D, Toumi M, Angermeyer MC (2006). The impact of caregivers' characteristics, patients' conditions and regional differences on family burden in schizophrenia: a longitudinal analysis. Acta Psychiatrica Scandinavica 114, 363-374.
40. Siegel SJ, Irani F, Brensinger CM, Kohler CG, Bilker WB, Ragland JD, Kanes SJ, Gur RC, Gur RE (2006). Prognostic variables at intake and long-term level of function in schizophrenia. American Journal of Psychiatry 163, 433-441.
41. Strauss JS, Carpenter Jr. WT (1974). The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: a report from the WHO international pilot study of schizophrenia. Archives of General Psychiatry 31, 37-42.
42. Tarrier N, Barrowclough C, Porceddu K, Fitzpatrick E (1994). The Salford Family Intervention Project: relapse rates of schizophrenia at five and eight years. British Journal of Psychiatry 165, 829-832.
43. Vaughn CE, Snyder KS, Jones S, Freeman WB, Falloon IR (1984). Family factors in schizophrenic relapse. Replication in California of British research on expressed emotion. Archives of General Psychiatry 41, 1169-1177.
44. WHO (1988). WHO Psychiatric Disability Assessment Schedule (WHO-DAS). World Health Organization: Geneva
45. WHO (2002). Anatomical Therapeutic Chemical Classification Index. Collaborating Centre for Drug Statistics Methodology. World Health Organization: Geneva.
46. Wing JK, Bennett DH, Denham J (1964). The Industrial Rehabilitation of Long-stay Schizophrenic Patients. Medical Research Council Memo no. 42. HMSO: London.
47. Xiong W, Phillips MR, Hu X, Wang R, Dai Q, Kleinman J, Kleinman A (1994). Family based intervention for schizophrenic patients in China: a randomised controlled trial. British Journal of Psychiatry 165, 239-247.
48. Zubin J, Spring B (1977). Vulnerability. A new view of schizophrenia. Journal of Abnormal Psychology 86, 103-126.